Penbraya: A Pentavalent Meningococcal Vaccine
Penbraya: A Pentavalent Meningococcal Vaccine
March 18, 2024 (Issue: 1698)
The FDA has licensed Penbraya (Pfizer), a pentavalent
polysaccharide conjugate meningococcal
vaccine, for prevention of invasive meningococcal
disease caused by Neisseria meningitidis
serogroups A, B, C, W, or Y (MenABCWY) in persons
10-25 years...more
- MenQuadfi – a new meningococcal (A, C, W, and Y) vaccine. Med Lett Drugs Ther 2021; 63:78.
- CDC. Meningococcal Disease. Surveillance. Available at: https://bit.ly/3IeDxeb. Accessed February 29, 2024.
- LA McNamara et al. Detection of ciprofloxacin-resistant, β-lactamase-producing Neisseria meningitidis serogroup Y isolates – United States, 2019-2020. MMWR Morb Mortal Wkly Rep 2020; 69:735. doi:10.15585/mmwr.mm6924a2
- J Peterson et al. Immunogenicity and safety of a pentavalent meningococcal ABCWY vaccine in adolescents and young adults: an observer-blind, active-controlled, randomised trial. Lancet Infect Dis 2023; 23:1370. doi:10.1016/s1473-3099(23)00191-3
- SA Mbaeyi et al. Meningococcal vaccination: recommendations of the Advisory Committee on Immunization Practices, United States, 2020. MMWR Recomm Rep 2020; 69(9):1. doi:10.15585/mmwr.rr6909a1
- CDC. Meningococcal vaccine recommendations. November 20, 2023. Available at: https://bit.ly/3Ifpsgq. Accessed February 29, 2024.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.
Would you like to read the rest of this article? Gain access below.
Subscribe
Subscriptions to
The Medical Letter on Drugs and Therapeutics include:
- Print version published and mailed biweekly (26 issues/year)
- Unlimited online access to current and past issues (1988 - present)
- Mobile App
- FREE online per issue CME/CE
Purchase this article:
Title: Penbraya: A Pentavalent Meningococcal Vaccine
Article code: 1698b
Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.
